Joseph C. C. Huang
Direktor/Vorstandsmitglied bei DiagCor Bioscience, Inc. Ltd.
Profil
Dr. Joseph C.
Huang is Vice President at Kenson Ventures LLC.
He has an extensive knowledge and experience in the biotech industry.
He is an expert in the screening and selecting portfolio companies for investment.
Prior to joining Kenson Ventures in June 1999, Dr. Huang was the Head of Molecular Biomedical Research Department at Clontech Laboratories, Inc., since 1995.
He was responsible for setting up a new department and managing multi-million dollar therapeutic target discovery contract research programs for several major pharmaceutical companies.
Prior to Clontech, he was a senior scientist and project leader at Genelabs, Inc., since 1986.
He was involved in molecular cloning of novel hepatitis viruses as well as in developing diagnostic tests for detecting hepatitis viruses.
He also participated in developing new tools for use in screening small molecule drugs.
Before Genelabs, he was a postdoctoral fellow in the laboratory of Dr. Michael Bishop, a Nobel Laureate, at University of California, San Francisco.
Dr. Huang received his Ph.D.
in Chemistry from University of California, Berkeley.
Aktive Positionen von Joseph C. C. Huang
| Unternehmen | Position | Beginn |
|---|---|---|
Kenson Ventures LLC
 Kenson Ventures LLC Investment ManagersFinance Kenson Ventures LLC (Kenson Ventures) is a venture capital firm founded in 1999 by Kenneth Fong. The firm is headquartered in in Palo Alto, California. | Private Equity Investor | 02.06.1999 |
DiagCor Bioscience, Inc. Ltd.
 DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Joseph C. C. Huang
| Unternehmen | Position | Ende |
|---|---|---|
Takara Bio USA, Inc.
 Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Corporate Officer/Principal | 01.06.1999 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
Ausbildung von Joseph C. C. Huang
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kenson Ventures LLC
Kenson Ventures LLC Investment ManagersFinance Kenson Ventures LLC (Kenson Ventures) is a venture capital firm founded in 1999 by Kenneth Fong. The firm is headquartered in in Palo Alto, California. | Finance |
Takara Bio USA, Inc.
Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Health Services |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
DiagCor Bioscience, Inc. Ltd.
DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Health Technology |
